ClinicalTrials.Veeva

Menu

Studying Gene Expression and Location in Samples From Patients With Brain Tumors

C

Children's Oncology Group

Status

Completed

Conditions

Brain and Central Nervous System Tumors

Treatments

Genetic: genetic linkage analysis
Genetic: gene expression analysis
Genetic: microarray analysis
Other: immunohistochemistry staining method
Other: laboratory biomarker analysis

Study type

Observational

Funder types

NETWORK
NIH

Identifiers

NCT01585389
COG-ABTR12B3 (Other Identifier)
ABTR12B3 (Other Identifier)
CDR0000732178 (Other Identifier)
NCI-2012-00731 (Registry Identifier)

Details and patient eligibility

About

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to brain tumors.

PURPOSE: This research studies gene expression and location in samples from patients with brain tumors.

Full description

OBJECTIVES:

  • To determine the expression and subcellular localization of nei endonuclease VIII-like 3 (NEIL3) in brain tumors.

OUTLINE: Tissue microarray samples are analyzed for NEIL3 expression and subcellular localization by immunohistochemical methods.

Enrollment

10 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

DISEASE CHARACTERISTICS:

  • Tissue microarrays (TMA) samples from the Biopathology Core

  • Samples from patients diagnosed with brain tumors

    • Progenitor, or blast, cell origin

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems